Subjects who were treated with either latanoprost ophthalmic solution 0.005% or latanoprost-timolol maleate fixed combination ophthalmic solution in both eyes.
Conditions
Interventions
Eye drops once a day for 3 days
Sponsors
Tsukazaki Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy subjects who can apply eye drops
Exclusion criteria
Exclusion criteria: subjects who cannot apply eye drops
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| instill the medication for 3 days | — |
Countries
Japan
Contacts
Public ContactKazuaki Nishimura
Tsukazaki Hospital Ophthalmology
Outcome results
None listed